Gardasil 9 0,5 mL Injection
PDF Leaflet Revision Date: 18 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of HPV-related cancers and genital warts.
Dosage (summary)
3 doses of 0.5 mL IM: 0, 2, and 6 months; 2 doses for ages 9-14.
Special Populations
- Immunocompromised
- Elderly
- Children < 9 years
Pregnancy & Breastfeeding
Caution in pregnancy; safety not established. Administer with caution during lactation.
Key Drug Interactions
- Hormonal contraceptives
- Immunosuppressive therapies
Contraindications
- Hypersensitivity to vaccine components
Common side effects
- Headache
- Dizziness
- Nausea
- Fatigue
- Injection site reactions
Counselling Points
- Complete vaccination series
- Monitor for syncope post-vaccination
- Avoid during pregnancy
Serious warnings
- Anaphylactic reactions possible
- Not for treatment of active HPV diseases
Important Disclaimer
The Gardasil 9 0,5 mL Injection professional information leaflet below is the property of Msd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
